Surgery Partners, Inc. (SGRY)

Market Cap	3.21B
Revenue (ttm)	2.74B
Net Income (ttm)	-11.90M
Shares Out	126.61M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	24.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,107,817
Open	24.04
Previous Close	24.04
Day's Range	24.04 - 25.44
52-Week Range	22.05 - 45.79
Beta	2.74
Analysts	Strong Buy
Price Target	44.44 (+75.1%)
Earnings Date	May 7, 2024

About SGRY

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty phy...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 1, 2015
• Employees: 13,500
• Stock Exchange: NASDAQ
• Ticker Symbol: SGRY

Financial Performance

In 2023, SGRY's revenue was $2.74 billion, an increase of 8.03% compared to the previous year's $2.54 billion. Losses were -$11.90 million, -78.21% less than in 2022.

Analyst Forecast

According to 9 analysts, the average rating for SGRY stock is "Strong Buy." The 12-month stock price forecast is $44.44, which is an increase of 75.10% from the latest price.

Price Target

$44.44

(75.10% upside)

Analyst Consensus: Strong Buy